Graham is a Principal at Abingworth, based in the London office since 2022. Prior to joining Abingworth Graham worked with J&J’s corporate venture arm JJDC, Irish VC Seroba Life Sciences, and, founded and built Techspert, a healthcare-focused technology company. He brings significant experience in scaling early-stage ventures and navigating the challenges through development. At Abingworth Graham directly works with portfolio companies including Addition Therapeutics, Iambic Therapeutics, AdvanCell, and Antares Therapeutics.  

Graham earned his Ph.D. in Medical Biology from the University of Cambridge, preceded by a BA in Genetics from Trinity College Dublin.